Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;37:301-307

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dimitropoulou, C.
Right arrow Articles by Carrier, G. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dimitropoulou, C.
Right arrow Articles by Carrier, G. O.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*LOSARTAN POTASSIUM
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Ion channels/membrane transport
Right arrow Signal transduction
Right arrow Other Vascular biology

(Hypertension. 2001;37:301.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Angiotensin II Relaxes Microvessels Via the AT2 Receptor and Ca2+-Activated K+ (BKCa) Channels

Christiana Dimitropoulou; Richard E. White; Leslie Fuchs; Hanfang Zhang; John D. Catravas; Gerald O. Carrier

From the Department of Pharmacology and Toxicology (C.D., R.E.W., L.F., J.D.C., G.O.C.) and the Vascular Biology Center (L.F., H.Z., J.D.C.), Medical College of Georgia, Augusta.

Correspondence to Dr Gerald O. Carrier, Department of Pharmacology and Toxicology, Medical College of Georgia, 1120 15th St, Augusta, GA 30912-2300. E-mail gcarrier{at}mail.mcg.edu

Angiotensin II (Ang II) is one of the most potent vasoconstrictor substances, yet paradoxically, Ang II may dilate certain vascular beds via an undefined mechanism. Ang II–induced vasoconstriction is mediated by the AT1 receptor, whereas the relative expression and functional importance of the AT2 receptor in regulating vascular resistance and blood pressure are unknown. We now report that Ang II induces relaxation of mesenteric microvessels and that this vasodilatory response was unaffected by losartan, an AT1 receptor antagonist, but was inhibited by PD123,319, a selective antagonist of AT2 receptors. In addition, reverse transcriptase–polymerase chain reaction studies revealed high amounts of AT2 receptor mRNA in smooth muscle from these same microvessels. Ang II–induced relaxation was inhibited by either tetraethylammonium or iberiotoxin, suggesting involvement of the large-conductance, calcium- and voltage-activated potassium (BKCa) channel. Subsequent whole-cell and single-channel patch-clamp studies on single myocytes demonstrated that Ang II increases the activity of BKCa channels. As in our tissue studies, the effect of Ang II on BKCa channels was inhibited by PD123,319, but not by losartan. In light of these consistent findings from tissue physiology, molecular studies, and cellular/molecular physiology, we conclude that Ang II relaxes microvessels via stimulation of the AT2 receptor with subsequent opening of BKCa channels, leading to membrane repolarization and vasodilation. These findings provide evidence for a novel endothelium-independent vasodilatory effect of Ang II.


Key Words: angiotensin II • receptors, angiotensin • potassium channels • patch-clamp techniques




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. H. Lee, S. Xia, and L. Ragolia
Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R144 - R154.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Guilluy, M. Rolli-Derkinderen, L. Loufrani, A. Bourge, D. Henrion, L. Sabourin, G. Loirand, and P. Pacaud
Ste20-Related Kinase SLK Phosphorylates Ser188 of RhoA to Induce Vasodilation in Response to Angiotensin II Type 2 Receptor Activation
Circ. Res., May 23, 2008; 102(10): 1265 - 1274.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. S. Park, J.-H. Ko, N. Kim, Y. K. Son, S. H. Kang, M. Warda, I. D. Jung, Y.-M. Park, and J. Han
Increased Inhibition of Inward Rectifier K+ Channels by Angiotensin II in Small-Diameter Coronary Artery of Isoproterenol-Induced Hypertrophied Model
Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1768 - 1775.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J.-M. Vincent, Y. W. Kwan, S. Lung Chan, C. Perrin-Sarrado, J. Atkinson, and J.-M. Chillon
Constrictor and Dilator Effects of Angiotensin II on Cerebral Arterioles
Stroke, December 1, 2005; 36(12): 2691 - 2695.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. M. Gauthier, D. X. Zhang, E. M. Edwards, B. Holmes, and W. B. Campbell
Angiotensin II Dilates Bovine Adrenal Cortical Arterioles: Role of Endothelial Nitric Oxide
Endocrinology, August 1, 2005; 146(8): 3319 - 3324.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Guimaraes and H. Pinheiro
Functional evidence that in the cardiovascular system AT1 angiotensin II receptors are AT1B prejunctionally and AT1A postjunctionally
Cardiovasc Res, August 1, 2005; 67(2): 208 - 215.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. M. Duke, R. G. Evans, and R. E Widdop
AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive rats
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2289 - H2297.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. L. Pallone
Microvascular Effects of Aldosterone and Angiotensin Type 2 Receptors
Hypertension, May 1, 2005; 45(5): 845 - 846.
[Full Text] [PDF]


Home page
HypertensionHome page
M. Gonzalez, L. Lobos, F. Castillo, L. Galleguillos, N. C. Lopez, and L. Michea
High-Salt Diet Inhibits Expression of Angiotensin Type 2 Receptor in Resistance Arteries
Hypertension, May 1, 2005; 45(5): 853 - 859.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. You, L. Loufrani, C. Baron, B. I. Levy, R. E. Widdop, and D. Henrion
High Blood Pressure Reduction Reverses Angiotensin II Type 2 Receptor-Mediated Vasoconstriction Into Vasodilation in Spontaneously Hypertensive Rats
Circulation, March 1, 2005; 111(8): 1006 - 1011.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. W. Batenburg, I. M. Garrelds, C. C. Bernasconi, L. Juillerat-Jeanneret, J. P. van Kats, P. R. Saxena, and A.H. J. Danser
Angiotensin II Type 2 Receptor-Mediated Vasodilation in Human Coronary Microarteries
Circulation, May 18, 2004; 109(19): 2296 - 2301.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. P. Korovkina, A. M. Brainard, P. Ismail, T. J. Schmidt, and S. K. England
Estradiol Binding to Maxi-K Channels Induces Their Down-regulation via Proteasomal Degradation
J. Biol. Chem., January 9, 2004; 279(2): 1217 - 1223.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Koobi, J. Kalliovalkama, P. Jolma, J. Rysa, H. Ruskoaho, O. Vuolteenaho, M. Kahonen, I. Tikkanen, M. Fan, P. Ylitalo, et al.
AT1 Receptor Blockade Improves Vasorelaxation in Experimental Renal Failure
Hypertension, June 1, 2003; 41(6): 1364 - 1371.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. P. Bagby, L. S. LeBard, Z. Luo, B. E. Ogden, C. Corless, E. D. McPherson, and R. C. Speth
ANG II AT1 and AT2 receptors in developing kidney of normal microswine
Am J Physiol Renal Physiol, October 1, 2002; 283(4): F755 - F764.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. E. Widdop, K. Matrougui, B. I. Levy, and D. Henrion
AT2 Receptor-Mediated Relaxation Is Preserved After Long-Term AT1 Receptor Blockade
Hypertension, October 1, 2002; 40(4): 516 - 520.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Dimitropoulou, G. Han, A. W. Miller, M. Molero, L. C. Fuchs, R. E. White, and G. O. Carrier
Potassium (BKCa) currents are reduced in microvascular smooth muscle cells from insulin-resistant rats
Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H908 - H917.
[Abstract] [Full Text] [PDF]